2016
DOI: 10.1590/1414-431x20154853
|View full text |Cite
|
Sign up to set email alerts
|

Expression of BAFF and BR3 in patients with systemic lupus erythematosus

Abstract: The objective of this study was to examine the relationship between the expression of B cell activating factor (BAFF) and BAFF receptor in patients with disease activity of systemic lupus erythematosus (SLE). Real-time RT-PCR was used to examine BAFF mRNA expression in peripheral blood monocytes of active and stable SLE patients and healthy controls. The percentage of BAFF receptor 3 (BR3) on B lymphocytes was measured by flow cytometry. Soluble BAFF levels in serum were assayed by ELISA. Microalbumin levels w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 22 publications
1
10
0
Order By: Relevance
“…Accumulating evidence shows that BAFF is a crucial regulatory mediator in several inflammatory diseases (8). For example, BAFF expression is enhanced in patients with systemic lupus erythematosus or rheumatoid arthritis, and is positively associated with disease activity (19,20). Elevated BAFF levels were also found in the gastric mucosa of Helicobacter (Hp) positive patients with chronic gastritis (21).…”
Section: Discussionmentioning
confidence: 99%
“…Accumulating evidence shows that BAFF is a crucial regulatory mediator in several inflammatory diseases (8). For example, BAFF expression is enhanced in patients with systemic lupus erythematosus or rheumatoid arthritis, and is positively associated with disease activity (19,20). Elevated BAFF levels were also found in the gastric mucosa of Helicobacter (Hp) positive patients with chronic gastritis (21).…”
Section: Discussionmentioning
confidence: 99%
“…[28] Additionally, The expression of BAFF-R on CD19+ cells (B cells) in active SLE patients was elevated in stable SLE patients. (Duan, J.H., et al, 2016) Although BAFF-R stands as a specific receptor for both soluble and membrane-bound BAFF, TACI and BCMA can also bind to them. (Liu, Z., A. Davidson, 2011) This study showed significant elevation of TACI&decrease of BCMA levels in RA &SLE cases in comparison with control subjects.…”
Section: Discussionmentioning
confidence: 99%
“…The expression of BAFF-R on CD19+ cells (B cells) in active SLE patients was downregulated compared to those in stable SLE patients and controls and the expression of BAFF-R on CD19+ cells was negatively correlated with serum BAFF levels and BAFF mRNA levels in PBMCs [74]. Thus, elevated BAFF in serum and PBMCs and a reduced expression of BAFF-R and overexpression of TACI on B cells were demonstrated in SLE.…”
Section: Systemic Lupus Erythematosusmentioning
confidence: 98%
“…In another SLE cohort of 60 patients, the peripheral blood leukocyte levels of BAFF mRNA were correlated with the serum BAFF protein levels and the BAFF mRNA levels were more closely associated with serum immunoglobulin levels and SLEDAI scores than were the serum BAFF protein levels [73]. In 75 SLE patients, elevated serum BAFF and elevated PBMC BAFF mRNA levels in active SLE patients were observed compared with those in stable SLE patients and controls and those levels in active SLE patients with proteinuria were higher than those in active SLE patients without proteinuria [74].…”
Section: Systemic Lupus Erythematosusmentioning
confidence: 99%